{"id":"W4409722550","doi":"10.1007/s40273-025-01488-x","title":"Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada","year":2025,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Alectinib; Medicine; Lung cancer; Quality of Life Research; Oncology; Chemotherapy; Health economics; Adjuvant chemotherapy; Internal medicine; Pharmacoeconomics; Cisplatin; Intensive care medicine; Public health; Cancer; Crizotinib; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00143635,0.0006510011,0.0006919186,0.0006845291,0.0008469885,0.001500271,0.001178769,0.0006148955,0.002187982],"category_scores_gemma":[0.005965614,0.0003380344,0.001315463,0.001129571,0.0006325898,0.0005262859,0.0007847606,0.0007842272,0.0001036018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07310405,"about_ca_system_score_gemma":0.05029958,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9573946,"about_ca_topic_score_gemma":0.9578058,"domain_scores_codex":[0.9992042,0.0002722004,0.000033778,0.00009531835,0.0001492319,0.0002452571],"domain_scores_gemma":[0.9984369,0.0006161702,0.0002046882,0.00003106214,0.0003866917,0.0003244733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.00533284,0.0003990895,0.1179406,0.0005462827,0.001122388,0.0005476202,0.0001883,0.8315413,0.0005466217,0.005424235,0.005155766,0.03125501],"study_design_scores_gemma":[0.002141703,0.001220553,0.07986541,0.000435174,0.00148089,0.0003415575,0.000835109,0.904511,0.0008690798,0.003471694,0.004705227,0.0001225989],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750538,0.003839566,0.00254254,0.00350763,0.00004467246,0.0004581151,0.006004253,0.00005193773,0.008497455],"genre_scores_gemma":[0.9968843,0.0006098627,0.0008540543,0.0001242371,0.000004014528,0.00003931494,0.0009158821,0.000005220724,0.0005630561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07310405,"threshold_uncertainty_score":0.5304095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01368345378869803,"score_gpt":0.3488611628773168,"score_spread":0.3351777090886188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}